Sharps Technology, Inc. (STSS) |
1.36 0 (0%)
|
01-27 16:00 |
Open: |
1.35 |
Pre. Close: |
1.36 |
High:
|
1.4 |
Low:
|
1.35 |
Volume:
|
90,071 |
Market Cap:
|
13(M) |
|
|
Technical analysis |
as of: 2023-01-27 4:48:18 PM |
Overall:
|
|
Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
Target: |
Six months: 1.93 One year: 2.32 |
Support: |
Support1: 1.12 Support2: 0.93 |
Resistance: |
Resistance1: 1.65 Resistance2: 1.99 |
Pivot: |
1.49  |
Moving Average: |
MA(5): 1.38 MA(20): 1.42 
MA(100): 1.24 MA(250): 0 |
MACD: |
MACD(12,26): 0 Signal(9): 0  |
Stochastic oscillator: |
%K(14,3): 22.5 %D(3): 27  |
RSI: |
RSI(14): 48.3  |
52-week: |
High: 3.61 Low: 0.81 |
Average Vol(K): |
3-Month: 91 (K) 10-Days: 70 (K) |
|
Price, moving averages and Bollinger Bands |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ STSS ] has closed above bottom band by 20.6%. Bollinger Bands are 29.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
Stock Price Prediction |
Update at 5:00pm EST |
If tomorrow:
|
Open lower
|
Open higher
|
High:
|
1.4 - 1.41 |
1.41 - 1.42 |
Low:
|
1.33 - 1.34 |
1.34 - 1.35 |
Close:
|
1.35 - 1.36 |
1.36 - 1.37 |
|
Company Description |
Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York. |
Headline News |
Sat, 28 Jan 2023 Bears 2022 STs review: Cairo Santos takes step back - Yahoo Sports
Fri, 27 Jan 2023 Archambault to close its iconic store at Ste-Catherine and Berri Sts. - Montreal Gazette
Thu, 26 Jan 2023 STS Apologizes for Ex-President's Speech Amid Twitter Backlash - Medscape
Tue, 24 Jan 2023 Diocese of Columbus to close Sts. Peter and Paul School - WSAZ
Tue, 24 Jan 2023 Thomas E. MacGillivray, MD, Elected president of The Society of ... - Diagnostic and Interventional Cardiology
Mon, 23 Jan 2023 Torrey Pines student follows up International Mathematical ... - Del Mar Times
|
Financial Analysis |
Price to Book Value: |
Outperform |
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Price to Earnings: |
Underperform |
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Discounted cash flow: |
Outperform |
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Return on Assets: |
Underperform |
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Return on Equity: |
Underperform |
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Debt to Equity: |
Neutral |
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
Free Technical Analysis Charts
|
|
Stock Basics & Statistics |
Exchange: NASDAQ |
Sector: Healthcare |
Industry: Medical Instruments & Supplies |
Shares Out. |
0 (M) |
Shares Float |
5 (M) |
% Held by Insiders
|
40.2 (%) |
% Held by Institutions
|
2.6 (%) |
Shares Short
|
43 (K) |
Shares Short P.Month
|
88 (K) |
Stock Financials |
EPS
|
0 |
EPS Est Next Qtl
|
0 |
EPS Est This Year
|
0 |
EPS Est Next Year
|
0 |
Book Value (p.s.)
|
0 |
Profit Margin (%)
|
0 |
Operating Margin (%)
|
0 |
Return on Assets (ttm)
|
0 |
Return on Equity (ttm)
|
0 |
Qtrly Rev. Growth
|
0 |
Gross Profit (p.s.)
|
0 |
Sales Per Share
|
0 |
EBITDA (p.s.)
|
-0.77 |
Qtrly Earnings Growth
|
0 |
Operating Cash Flow
|
-5 (M) |
Levered Free Cash Flow
|
0 (M) |
Stock Valuations |
PE Ratio
|
0 |
PEG Ratio
|
0 |
Price to Book value
|
0 |
Price to Sales
|
0 |
Price to Cash Flow
|
-0 |
Stock Dividends |
Dividend
|
0 |
Forward Dividend
|
0 |
Dividend Yield
|
0% |
Dividend Pay Date
|
Invalid DateTime. |
Ex-Dividend Date
|
Invalid DateTime. |
Your Ad Here
|
|